Phase IIb Clinical Study to Assess the Efficacy and Safety of GenSci120 Injection in Patients With Moderately to Severely Active RA Who Have an Inadequate Response to at Least One DMARD

Abroad (travel likely)RecruitingPHASE2

Conditions

Rheumatoid Arthritis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Peking University People's Hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (Zhanguo LI, Doctor) · li99@bjmu.edu.cn · 010-88378021

Study leads

Zhanguo LI, Doctor
Study Chair
Peking University People's Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)

Active Rheumatoid Arthritis

Abroad (travel likely)RecruitingPHASE2

Gilbert, United States · Glendale, United States

Effect of Roflumilast as Add-On Therapy in Rheumatoid Arthritis

Rheumatoid Arthritis · Rheumatoid Arthritis (RA)

Abroad (travel likely)RecruitingPHASE2

Al Mansurah, Egypt

Fexofenadine in Patients With Active Rheumatoid Arthritis

Rheumatoid Arthritis

Abroad (travel likely)RecruitingPHASE1, PHASE2

Banī Suwayf, Egypt · Banī Suwayf, Egypt

Phase 1b/2 Study of IV Sarilumab in Adult With RA

Rheumatoid Arthritis

Abroad (travel likely)RecruitingPHASE1, PHASE2

Hollywood, United States · Plano, United States